Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maarouf, M.
Right arrow Articles by Sturm, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maarouf, M.
Right arrow Articles by Sturm, V.
Related Collections
Right arrow Radiation therapy-tumor
Right arrow Arteriovenous malformation
Right arrow All Genetics
NEUROLOGY 2004;63:367-369
© 2004 American Academy of Neurology
Brief Communications

Radiosurgery for cerebral arteriovenous malformations in hereditary hemorrhagic telangiectasia

M. Maarouf, MD, M. Runge, MD, M. Kocher, MD, M. Zähringer, MD, H. Treuer, PhD and V. Sturm, MD

From the Departments of Stereotactic and Functional Neurosurgery (Drs. Maarouf, Runge, Treuer, and Sturm), Radiation Oncology (Dr. Kocher), and Radiology (Dr. Zähringer), University of Cologne, Germany.

Address correspondence and reprint requests to Dr. Mohammad Maarouf, Department of Stereotactic and Functional Neurosurgery, University of Cologne, Joseph-Stelzmann-Strasse 9, D-50924 Cologne, Germany; e-mail: m.maarouf{at}uni-koeln.de

The authors evaluated the efficacy of radiosurgery (RS) for cerebral arteriovenous malformations in hereditary hemorrhagic telangiectasia (HHT AVMs). Two patients with seven HHT AVMs were treated by linear accelerator-RS. Complete obliteration was achieved 18 to 24 months post-treatment without side effects. Because HHT AVMs are small and multiple, RS is superior to microsurgery because it is noninvasive and all AVMs can be treated in one session regardless of their location.

Received May 16, 2003. Accepted in final form March 8, 2004.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.